| [1] |
陈规划,汪根树．肝移植受者生存质量:现状、问题与对策[J]．器官移植, 2013, 4(1): 1-5.
|
| [2] |
Chabowski A,Żendzian-Piotrowska M,Konstantynowicz K, et al. Fatty acid transporters involved in the palmitate and oleate induced insulin resistance in primary rat hepatocytes[J]. Acta Physiol, 2013, 207(2): 346-357.
|
| [3] |
Bonen A,Campbell SE,Benton CR, et al. Regulation of fatty acid transport by fatty acid translocase/CD36[J]. Proc Nutr Soc, 2004, 63(2): 245-249.
|
| [4] |
Xu S,Jay A,Brunaldi K, et al. CD36 enhances fatty acid uptake by increasing the rate of intracellular esterification but not transport across the plasma membrane[J]. Biochemistry, 2013, 52(41): 7254-7261.
|
| [5] |
Abumrad N,Harmon C,Ibrahimi A. Membrane transport of long-chain fatty acids: evidence for a facilitated process[J]. J Lipid Res, 1998, 39(12): 2309-2318.
|
| [6] |
Harmon CM,Abumrad NA. Binding of sulfosuccinimidyl fatty acids to adipocyte membrane proteins: isolation and amino-terminal sequence of an 88-kD protein implicated in transport of long-chain fatty acids[J]. J Membr Biol, 1993, 133(1): 43-49.
|
| [7] |
Krammer J,Digel M,Ehehalt F, et al. Overexpression of CD36 and acyl-CoA synthetases FATP2, FATP4 and ACSL1 increases fatty acid uptake in human hepatoma cells[J]. Int J Med Sci, 2011, 8(7): 599-614.
|
| [8] |
Buqué X,Cano A,Miquilena-Colina ME, et al. High insulin levels are required for FAT/CD36 plasma membrane translocation and enhanced fatty acid uptake in obese Zucker rat hepatocytes[J]. Am J Physiol Endocrinol Metab, 2012, 303(4): E504-E514.
|
| [9] |
Petta S,Handberg A,Marchesini G, et al. High sCD36 plasma level is associated with steatosis and its severity in patients with genotype 1 chronic hepatitis C[J]. J Viral Hepat, 2013, 20(3): 174-182.
|
| [10] |
García-Monzón C,Lo Iacono O,Crespo J, et al. Increased soluble CD36 is linked to advanced steatosis in nonalcoholic fatty liver disease[J]. Eur J Clin Invest, 2014, 44(1): 65-73.
|
| [11] |
Nishikawa S,Sugimoto J,Okada M, et al. Gene expression in livers of BALB/C and C57BL/6J mice fed a high-fat diet[J]. Toxicol Pathol, 2012, 40(1): 71-82.
|
| [12] |
Satoh H,Ide N,Kagawa Y, et al. Hepatic steatosis with relation to increased expression of peroxisome proliferator-activated receptor-γ in insulin resistant mice[J]. Biol Pharm Bull, 2013, 36(4): 616-623.
|
| [13] |
Ma Y,Huang Y,Yan L, et al. Synthetic FXR agonist GW4064 prevents diet-induced hepatic steatosis and insulin resistance[J]. Pharm Res, 2013, 30(5): 1447-1457.
|
| [14] |
Guo F,Yang X,Li X, et al. Nuciferine prevents hepatic steatosis and injury induced by a high-fat diet in hamsters[J]. PLoS One, 2013, 8(5): e63770.
|
| [15] |
Trombetta A,Togliatto G,Rosso A, et al. Increase of palmitic acid concentration impairs endothelial progenitor cell and bone marrow-derived progenitor cell bioavailability: role of the STAT5/PPARγ transcriptional complex[J]. Diabetes, 2013, 62(4): 1245-1257.
|
| [16] |
Madonna R,Salerni S,Schiavone D, et al. Omega-3 fatty acids attenuate constitutive and insulin-induced CD36 expression through a suppression of PPAR α/γ activity in microvascular endothelial cells[J]. Thromb Haemost, 2011, 106(3): 500-510.
|
| [17] |
Morán-Salvador E,López-Parra M,García-Alonso V, et al. Role for PPARγ in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts[J]. FASEB J, 2011, 25(8): 2538-2550.
|
| [18] |
Clugston RD,Yuen JJ,Hu Y, et al. CD36-deficient mice are resistant to alcohol- and high-carbohydrate-induced hepatic steatosis[J]. J Lipid Res, 2014, 55(2): 239-246.
|